Efficacy and Safety of OncoGel™ Added to Chemotherapy and Radiation Before Surgery in Subjects With Esophageal Cancer

NCT00573131 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

137

Enrollment

INDUSTRY

Sponsor class

Stopped OncoGel did not show any impact on overall tumor response

Conditions

Esophageal Cancer
Adenocarcinoma of the Esophagus
Squamous Cell Carcinoma

Interventions

DRUG: OncoGel (Paclitaxel gel)
DRUG: cisplatin
DRUG: 5-FU
RADIATION: radiation therapy
PROCEDURE: esophageal resection

Sponsor

Boston Scientific Corporation